BioLife Solutions BLFS
$0.00 +$0.00 (0.00%)
Market closed · Oct 22, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$28.47M+21.5% YoY
Operating profit$1.70M+110.5% YoY
Net profit$45.10M+384.8% YoY
Diluted EPS$0.91+375.8% YoY
Free cash flow$5.19M-7.8% YoY
Operating cash flow$6.35M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin63.6%
Operating margin1.6%
Net margin54.3%
Return on equity15.1%
Return on assets13.9%
Return on invested capital14.4%
Current ratio9.69
Liabilities / assets6.1%
Cash & investments$82.42M
Total debt$13.15M
Net cash (debt)$69.27M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $28.47M | $27.50M | $96.21M | $18.79M | $28.07M |
| Total Operating Revenue | $28.47M | $27.50M | $96.21M | $18.79M | $28.07M |
| Cost of Revenue | $10.18M | $10.00M | $34.10M | $6.81M | $10.15M |
| Gross Profit | $18.29M | $17.50M | $62.12M | $11.98M | $17.92M |
| Operating Expense | $16.59M | $17.47M | $78.72M | $10.63M | $18.01M |
| Selling and Admin Expenses | $13.48M | $14.73M | $55.37M | $12.54M | $14.60M |
| -Selling & Marketing Expense | $2.78M | $2.53M | $9.85M | $1.99M | $2.53M |
| -General & Admin Expense | $10.69M | $12.21M | $45.52M | $10.55M | $12.07M |
| Research & Development | $2.96M | $2.65M | $23.09M | -$67,000.00 | $2.71M |
| Depreciation & Amortization & Depletion | $157,000.00 | $85,000.00 | $263,000.00 | -$1.85M | $699,000.00 |
| -Depreciation & Amortization | $157,000.00 | $85,000.00 | $263,000.00 | -$1.85M | $699,000.00 |
| Operating Profit | $1.70M | $27,000.00 | -$16.60M | $1.35M | -$89,000.00 |
| Net Non-Operating Interest Income (Expense) | $994,000.00 | $1.04M | $2.71M | $833,000.00 | $508,000.00 |
| Non-Operating Interest Income | $994,000.00 | $1.04M | – | – | – |
| Other Income (Expense) | $63,000.00 | $180,000.00 | $1.82M | $1.18M | $284,000.00 |
| Other Non-Operating Income (Expenses) | $63,000.00 | $180,000.00 | $1.82M | $1.18M | $284,000.00 |
| Pretax Profit | $2.75M | $1.25M | -$12.08M | $3.36M | $703,000.00 |
| Tax | -$42.35M | $62,000.00 | $49,000.00 | -$173,000.00 | $82,000.00 |
| Net Profit | $45.10M | $1.19M | -$4.60M | $11.07M | $621,000.00 |
| Profit from Continuing Operations | $45.10M | $1.19M | -$12.13M | $3.54M | $621,000.00 |
| Net Income from Discontinuous Operations | $0.00 | $0.00 | $7.54M | $7.54M | $0.00 |
| Net Income to Parent Company | $45.10M | $1.19M | -$4.60M | $11.07M | $621,000.00 |
| Net Income to Common Stockholders | $45.10M | $1.19M | -$4.60M | $11.07M | $621,000.00 |
| Basic EPS | $0.92 | $0.02 | -$0.09 | $0.23 | $0.01 |
| Diluted EPS | $0.91 | $0.02 | -$0.10 | $0.22 | $0.01 |
| Total Other Finance Costs | – | – | -$2.71M | -$833,000.00 | -$508,000.00 |
| Special Income (Charges) | – | – | $0.00 | – | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | $0.00 | – | – |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $447.49M | $400.91M | $405.88M | $405.88M | $392.08M |
| Total Current Assets | $135.20M | $133.22M | $136.56M | $136.56M | $126.57M |
| Cash and Cash Equivalents & Short-Term Investments | $82.42M | $81.00M | $88.93M | $88.93M | $78.95M |
| -Cash and Cash Equivalents | $24.00M | $22.82M | $33.04M | $33.04M | $29.48M |
| -Short Term Investments | $58.42M | $58.17M | $55.89M | $55.89M | $49.47M |
| Receivables | $10.65M | $13.06M | $7.95M | $7.95M | $10.84M |
| -Accounts Receivable | $10.65M | $13.06M | $7.95M | $7.95M | $10.84M |
| Inventory | $35.59M | $32.83M | $30.16M | $30.16M | $27.83M |
| Other Current Assets | $6.54M | $6.34M | $9.53M | $9.53M | $8.95M |
| Total Non-Current Assets | $312.30M | $267.68M | $269.32M | $269.32M | $265.52M |
| Net PPE | $23.88M | $21.62M | $22.18M | $22.18M | $18.73M |
| -Gross PPE | $29.65M | $26.98M | $27.11M | $27.11M | $23.68M |
| -Accumulated Depreciation | -$5.77M | -$5.36M | -$4.93M | -$4.93M | -$4.95M |
| Investments and Advances | $30.65M | $30.50M | $31.25M | $31.25M | $19.44M |
| -Available for Sale Securities | $30.65M | $30.50M | $31.25M | $31.25M | $19.44M |
| Goodwill and Other Intangible Assets | $212.24M | $212.52M | $212.84M | $212.84M | $219.75M |
| -Goodwill | $208.59M | $208.59M | $208.59M | $208.59M | $212.30M |
| -Other Intangible Assets | $3.65M | $3.93M | $4.26M | $4.26M | $7.45M |
| Non-Current Deferred Assets | $42.23M | – | – | – | – |
| Other Non-Current Assets | $3.29M | $3.05M | $3.05M | $3.05M | $7.58M |
| Total Liabilities | $27.49M | $28.68M | $34.00M | $34.00M | $38.34M |
| Total Current Liabilities | $13.95M | $18.25M | $22.98M | $22.98M | $27.15M |
| Payables | $4.60M | $5.95M | $3.77M | $3.77M | $6.57M |
| -Accounts Payable | $2.48M | $3.75M | $1.49M | $1.49M | $2.89M |
| -Total Tax Payable | $2.12M | $2.20M | $2.28M | $2.28M | $3.68M |
| Current Accrued Expenses | $2.70M | $3.26M | $5.85M | $5.85M | $5.91M |
| Short-Term Debt and Capital Lease Obligation | $2.59M | $4.82M | $7.24M | $7.24M | $9.67M |
| -Current Capital Lease Obligation | $2.59M | $2.32M | $2.24M | $2.24M | $2.18M |
| Current Deferred Liabilities | $188,000.00 | $206,000.00 | $195,000.00 | $195,000.00 | $154,000.00 |
| Total Non-Current Liabilities | $13.54M | $10.42M | $11.02M | $11.02M | $11.20M |
| Long Term Debt and Capital Lease Obligation | $13.15M | $10.04M | $10.66M | $10.66M | $11.01M |
| -Long Term Capital Lease Obligation | $13.15M | $10.04M | $10.66M | $10.66M | $11.01M |
| Non-Current Deferred Liabilities | $0.00 | $198,000.00 | $189,000.00 | $189,000.00 | $189,000.00 |
| Other Non-Current Liabilities | $399,000.00 | $183,000.00 | $171,000.00 | $171,000.00 | – |
| Total Equity | $420.00M | $372.23M | $371.89M | $371.89M | $353.74M |
| Stockholders' Equity | $420.00M | $372.23M | $371.89M | $371.89M | $353.74M |
| Capital Stock | $49,000.00 | $49,000.00 | $48,000.00 | $48,000.00 | $48,000.00 |
| -Common Stock | $49,000.00 | $49,000.00 | $48,000.00 | $48,000.00 | $48,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $713.57M | $710.81M | $711.40M | $711.40M | $704.33M |
| Retained Earnings | -$293.41M | -$338.51M | -$339.70M | -$339.70M | -$350.77M |
| Gains/Losses Not Affecting Retained Earnings | -$211,000.00 | -$120,000.00 | $132,000.00 | $132,000.00 | $130,000.00 |
| -Current Debt | – | $2.50M | $5.00M | $5.00M | $7.49M |
| -Long Term Equity Investment | – | – | $0.00 | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.35M | -$491,000.00 | $20.12M | $4.92M | $6.10M |
| Net cash flow from continuing operations | $6.35M | -$491,000.00 | $20.12M | $4.92M | $6.10M |
| Net Income from Continuing Operations | $45.10M | $1.19M | -$4.60M | $11.07M | $621,000.00 |
| Depreciation & Depletion & Amortization | $809,000.00 | $699,000.00 | $4.69M | $586,000.00 | $1.34M |
| Deferred Tax | -$42.43M | $9,000.00 | $65,000.00 | $0.00 | $14,000.00 |
| Other Non-Cash Items | $1.85M | -$188,000.00 | $17.40M | -$118,000.00 | $1.32M |
| Change in Working Capital | -$2.76M | -$6.88M | -$8.91M | -$2.24M | -$2.99M |
| -Change in Receivables | $2.41M | -$5.10M | $264,000.00 | $1.94M | -$782,000.00 |
| -Change in Inventory | -$2.76M | -$2.68M | -$1.27M | -$2.33M | -$197,000.00 |
| -Change in Prepaid Assets | -$246,000.00 | $3.22M | -$3.04M | -$462,000.00 | -$3.00M |
| -Change in Payables and Accrued Expense | -$2.16M | -$2.34M | -$5.14M | -$1.66M | $990,000.00 |
| -Change In Other Working Capital | $0.00 | $26,000.00 | $264,000.00 | – | – |
| Net cash flow from investing | -$1.58M | -$1.83M | -$71.54M | $1.14M | -$5.97M |
| Net Cash Flow from Continuing Investing Activities | -$1.58M | -$1.83M | -$71.54M | $1.14M | -$5.97M |
| Net PPE Purchase and Sale | -$1.04M | -$167,000.00 | -$9.48M | -$4.26M | -$3.30M |
| Net Investment Purchase and Sale | -$416,000.00 | -$1.66M | -$74.47M | -$18.02M | -$2.29M |
| Financing Cash Flow | -$3.59M | -$7.90M | -$10.92M | -$2.50M | -$2.56M |
| Net Cash Flow from Continuing Financing Activities | -$3.59M | -$7.90M | -$10.92M | -$2.50M | -$2.56M |
| Net Issuance Payments Of Debt | -$2.50M | -$2.50M | -$10.00M | -$2.50M | -$2.50M |
| Proceeds from Stock Option Exercised | $3,000.00 | $190,000.00 | $18,000.00 | $0.00 | $0.00 |
| Net Other Financing Charges | -$1.10M | -$5.59M | -$942,000.00 | $4,000.00 | -$58,000.00 |
| Ending Cash Balance | $24.00M | $22.82M | $33.04M | $33.04M | $29.48M |
| Net Change in Cash | $1.18M | -$10.22M | -$62.35M | $3.56M | -$2.42M |
| Beginning Cash Balance | $22.82M | $33.04M | $95.39M | $29.48M | $31.90M |
| Free Cash Flow | $5.19M | -$658,000.00 | $416,000.00 | -$9.56M | $2.80M |
| Gain/Loss from Continuing Operations | – | – | -$9.80M | -$10.31M | $167,000.00 |
| -Change in Other Current Liabilities | – | – | $5,000.00 | – | – |
| Net Intangibles Purchase and Sale | – | – | -$10.22M | – | – |
| Net Business Purchase and Sale | – | – | $23.52M | $33.74M | $0.00 |
| Net Other Investing Changes | – | – | -$886,000.00 | -$101,000.00 | -$373,000.00 |
| Net Common Stock Issuance | – | – | $0.00 | – | – |
| Effect of Exchange Rate Changes | – | – | $0.00 | $0.00 | – |
No comments yet — be the first to weigh in on BLFS.
Sign in to join the discussion.